Bull Moose In the News: Week of 11/15-11/21/25

Two therapies approved by the Food and Drug Administration (FDA) now exist to slow Alzheimer's disease progression in early-stage patients by targeting amyloid plaque buildup – a hallmark of the disease – in the brain.

Published in Newsmax on Nov. 17

Amazon Wants Warner Bros. So It Can Rule Your Screen

The company that strong-arms small businesses now hopes to dominate entertainment by swallowing one of Hollywood’s biggest content libraries.


Published in Blaze Media on Nov. 18

Republicans Can Reclaim the Moral High Ground by Fighting Alzheimer's

A nation in crisis needs leaders who defend the vulnerable, cut delays, and deliver real care. Voters reward that courage — and punish those who hide behind rules.

Published in Blaze Media on Nov. 19

A New Nuclear Order

The Nuclear Non-Proliferation Treaty no longer serves the United States' interests in the multipolar twenty-first century. Instead, the NPT should be replaced by a new, foundational trilateral nuclear treaty.



Published in American Affairs on Nov. 20

Why AI Transparency is Critical for National Security

Unchecked AI development poses growing national security risks, and secretive companies like Safe Superintelligence show why transparency and oversight can’t wait.


Published in The National Interest on Nov. 21

The Trump Corollary

The Trump administration is championing a rigorous expansion of the Monroe Doctrine that aligns with the America First agenda.

Published in DARC on Nov. 21